Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
Omeros Corporation (Nasdaq: OMER) today announced that two posters directed to zaltenibart (OMS906), Omeros’ investigational ...
来自MSN8 个月
AstraZeneca gets FDA approval for PNH drug Voydeya
AstraZeneca (NASDAQ:AZN) has received FDA approval for its drug Voydeya, also known as danicopan, as an add-on therapy to Ultomiris or Soliris in the treatment of extravascular hemolysis in adults ...
Business Wire6 天
Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
In PNH patients experiencing substantial extravascular hemolysis while receiving ravulizumab, zaltenibart monotherapy resulted in sustained clinically meaningful improvements in both hemoglobin ...